35
Growth Score in past quarter
pts
Heat Score 35 in past quarter
-12 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
RespiDx develops a device that enables the diagnosis of pneumonia and febrile disease.
- Yossi Aldar: Founding CEOPast Role: OmnySense, Founding CEO
Ian Solomon: Co-Founder and VP Business Development
About the Company
RespiDx develops a device that enables the diagnosis of pneumonia and febrile disease. The automatic diagnosis of pneumonia is based on WHO diagnostic criteria. RespiDx’s efforts are currently focused on optimizing the Company’s pneumonia diagnosis device for mass-manufacturing and market entry.